NCT01944696

Brief Summary

Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial. Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 18, 2013

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

June 16, 2016

Status Verified

June 1, 2016

Enrollment Period

2.8 years

First QC Date

September 12, 2013

Last Update Submit

June 15, 2016

Conditions

Keywords

hyperbilirubinemiaprematurityextremely low birth weight (ELBW)phototherapycycled phototherapyintermittent phototherapy

Outcome Measures

Primary Outcomes (1)

  • Brain stem auditory evoked response wave V latency

    a measure of transient or permanent bilirubin neurotoxicity

    35 wks postmenstrual age or discharge

Secondary Outcomes (1)

  • Peak Total Serum Bilirubin (tsb)

    14 days from birth

Other Outcomes (2)

  • Neurodevelopmental status

    2 years adjusted age

  • Survival

    Before discharge from the neonatal ICU and at 2 years adjusted age

Study Arms (2)

continuous (uninterrupted) phototherapy

ACTIVE COMPARATOR

standard phototherapy

Other: phototherapy

15 minute per hour cycled phototherapy

EXPERIMENTAL

15 minute per hour cycled phototherapy

Other: phototherapy

Interventions

Cycled versus continuous phototherapy during the first 2 wks after birth, both administered at bilirubin thresholds used in the NICHD Neonatal Network Phototherapy trial .

15 minute per hour cycled phototherapycontinuous (uninterrupted) phototherapy

Eligibility Criteria

AgeUp to 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • birth weight 401-1000 grams
  • age less than or equal to 24 hours

You may not qualify if:

  • hemolytic disease
  • major anomaly
  • overt nonbacterial infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

University of Alabama at Birmingham School of Medicine - UAB Hospital

Birmingham, Alabama, 35233, United States

RECRUITING

Stanford University - Lucile Packard Children's Hospital

Palo Alto, California, 94304, United States

NOT YET RECRUITING

University of Cincinnati College of Medicine - Good Samaritan Hospital

Cincinnati, Ohio, 45220, United States

RECRUITING

The University of Texas Southwestern Medical School - Clements University Hospital

Dallas, Texas, 75390, United States

RECRUITING

The University of Texas Health Science Center at Houston; Memorial Hermann-TMC-NICU

Houston, Texas, 77030, United States

RECRUITING

The University of Texas Health Science Center at San Antonio - University Hospital

San Antonio, Texas, 78229, United States

RECRUITING

Related Publications (3)

  • Tyson JE, Pedroza C, Langer J, Green C, Morris B, Stevenson D, Van Meurs KP, Oh W, Phelps D, O'Shea M, McDavid GE, Grisby C, Higgins R; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol. 2012 Sep;32(9):677-84. doi: 10.1038/jp.2012.64. Epub 2012 May 31.

    PMID: 22652561BACKGROUND
  • Hintz SR, Stevenson DK, Yao Q, Wong RJ, Das A, Van Meurs KP, Morris BH, Tyson JE, Oh W, Poole WK, Phelps DL, McDavid GE, Grisby C, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Is phototherapy exposure associated with better or worse outcomes in 501- to 1000-g-birth-weight infants? Acta Paediatr. 2011 Jul;100(7):960-5. doi: 10.1111/j.1651-2227.2011.02175.x. Epub 2011 Feb 25.

    PMID: 21272067BACKGROUND
  • Arnold C, Tyson JE, Pedroza C, Carlo WA, Stevenson DK, Wong R, Dempsey A, Khan A, Fonseca R, Wyckoff M, Moreira A, Lasky R. Cycled Phototherapy Dose-Finding Study for Extremely Low-Birth-Weight Infants: A Randomized Clinical Trial. JAMA Pediatr. 2020 Jul 1;174(7):649-656. doi: 10.1001/jamapediatrics.2020.0559.

MeSH Terms

Conditions

HyperbilirubinemiaPremature Birth

Interventions

Phototherapy

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Jon E Tyson, MD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
  • David K Stevenson, MD

    Stanford School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Vice Dean for Clinical Research and Healthcare Quality

Study Record Dates

First Submitted

September 12, 2013

First Posted

September 18, 2013

Study Start

March 1, 2014

Primary Completion

January 1, 2017

Study Completion

January 1, 2018

Last Updated

June 16, 2016

Record last verified: 2016-06

Locations